Steroidogenic disruptive effects of the serotonin-noradrenaline reuptake inhibitors duloxetine, venlafaxine and tramadol in the H295R cell assay and in a recombinant CYP17 assay.
about
Steroidogenic disruptive effects of the serotonin-noradrenaline reuptake inhibitors duloxetine, venlafaxine and tramadol in the H295R cell assay and in a recombinant CYP17 assay.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Steroidogenic disruptive effec ...... in a recombinant CYP17 assay.
@en
Steroidogenic disruptive effec ...... in a recombinant CYP17 assay.
@nl
type
label
Steroidogenic disruptive effec ...... in a recombinant CYP17 assay.
@en
Steroidogenic disruptive effec ...... in a recombinant CYP17 assay.
@nl
prefLabel
Steroidogenic disruptive effec ...... in a recombinant CYP17 assay.
@en
Steroidogenic disruptive effec ...... in a recombinant CYP17 assay.
@nl
P1433
P1476
Steroidogenic disruptive effec ...... d in a recombinant CYP17 assay
@en
P2093
Cecilie Hurup Munkboel
Julie Islin
P356
10.1016/J.TIV.2017.10.029
P577
2017-10-31T00:00:00Z